Cargando…
Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
Oncolytic viruses (OV) have recently emerged as a promising therapeutic modality in cancer treatment. OV selectively infect and kill tumor cells, while sparing untransformed cells. The direct cytotoxic effects combined with the capacity to trigger an immune response make OV an appealing combination...
Autores principales: | Zhao, Xing, Ouyang, Weiwei, Chester, Cariad, Long, Shiqi, Wang, Nianxue, He, Zhixu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602626/ https://www.ncbi.nlm.nih.gov/pubmed/28922411 http://dx.doi.org/10.1371/journal.pone.0184816 |
Ejemplares similares
-
Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018) -
Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway
por: Long, Shiqi, et al.
Publicado: (2021) -
Reovirus activated NK cells show enhanced cetuximab mediated antibody-dependent cellular cytotoxicity against colorectal cancer cells
por: Zhao, Xing, et al.
Publicado: (2015) -
Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020) -
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
por: Jennings, VA, et al.
Publicado: (2014)